{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fexpose-mash-formerly-nash-b427370f.simplecast.com%2Fepisodes%2Fovercoming-barriers-RnOvPi5Y","width":444,"version":"1.0","type":"rich","title":"Overcoming Barriers to MASLD/MASH Screening in Clinical Practice","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/bc2d8a5e-50fa-4e66-967c-16915bf87f1d/e1161233-4089-43d8-91c6-1fae6c77b5ed/mash-podcast-series-coverart.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/4399b110-6ea5-450e-bcfb-48fc49a9d6b6\" height=\"200\" width=\"100%\" title=\"Overcoming Barriers to MASLD/MASH Screening in Clinical Practice\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode of Expose MASH [formerly NASH], our experts will discuss some of the major barriers to screening for MASLD/MASH in the primary care and endocrinology settings. They will identify these barriers and misconceptions that contribute to the low rates of MASLD/MASH diagnosis, and provide their perspectives on how we can best overcome these challenges. This episode is brought to you by Novo Nordisk Inc."}